| Autor: |
Zojer, Niklas, Schuster-Kolbe, Judith, Assmann, Irene, Ackermann, Jutta, Strasser, Kathrin, Hübl, Wolfgang, Drach, Johannes, Ludwig, Heinz |
| Předmět: |
|
| Zdroj: |
British Journal of Haematology; Jun2002, Vol. 117 Issue 4, p852-859, 8p, 2 Charts |
| Abstrakt: |
Summary. In the present study, we aimed to identify distinct structural and numerical chromosomal aberrations in peripheral blood B cells of patients with myeloma and monoclonal gammopathy of undetermined significance (MGUS), which reflect changes thought to occur at different stages of the disease process. Peripheral blood from 12 patients with multiple myeloma and three patients with MGUS was investigated for the occurrence of retinoblastoma-1 gene deletions, p53 gene deletions and numerical aberrations demonstrated previously to be present in the patients' bone marrow CD138+ cells. By combining immunocytochemical staining for light chains and interphase fluorescence in situ hybridization (FISH), aberrant light-chain +ve cells were detected in the circulating CD19+ cell fraction. Each kind of chromosomal change present in the myeloma tumour cells was found to be shared by a small fraction of CD19+ cells (0·1–1·8%; median 0·36%, n = 6). In one MGUS patient, aberrant cells could be identified with a frequency of 0·34% within the CD19-sorted cell fraction. Clonotypic cells were detected with a frequency of 0·01–0·07% of peripheral blood nucleated cells by m-RNA in situ hybridization with patient-specific probes in three investigated patients. These results provide evidence that the circulating clonotypic B cells are closely related to the malignant plasma cells in myeloma and MGUS. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text